World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
84
Citations
23556
World Ranking
1392
National Ranking
711

Medicine

D-Index
84
Citations
23689
World Ranking
15199
National Ranking
7669

Stanley C. Jordan publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Stanley C. Jordan sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 463 publications — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Stanley C. Jordan D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Stanley C. Jordan sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 84 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Stanley C. Jordan is affiliated with Cedars-Sinai Medical Center in the United States and has contributed extensively to the field of medicine, particularly focusing on transplantation and immunology. Their research portfolio includes over 240 publications spanning several subfields, with notable emphasis on transplantation, immunology, infectious diseases, surgery, and nephrology.

The scientist's work covers a range of main topics, including:

  • Renal Transplantation Outcomes and Treatments
  • Renal Diseases and Glomerulopathies
  • SARS-CoV-2 and COVID-19 Research
  • Organ Transplantation Techniques and Outcomes
  • COVID-19 Clinical Research Studies
  • Complement system in diseases
  • Organ Donation and Transplantation

Stanley C. Jordan has authored significant papers such as:

  • Imlifidase Desensitization in Crossmatch-positive, Highly Sensitized Kidney Transplant Recipients: Results of an International Phase 2 Trial (Highdes), 2020, published in Transplantation
  • Innate and adaptive immune responses to SARS-CoV-2 in humans: relevance to acquired immunity and vaccine responses, 2021, Clinical & Experimental Immunology
  • T cell immune responses to SARS-CoV-2 and variants of concern (Alpha and Delta) in infected and vaccinated individuals, 2021, Cellular and Molecular Immunology
  • Compassionate Use of Tocilizumab for Treatment of SARS-CoV-2 Pneumonia, 2020, Clinical Infectious Diseases

The frequent coauthors collaborating with Stanley C. Jordan include Ashley Vo, Edmund Huang, Noriko Ammerman, Reiad Najjar, and Supreet Sethi.

Publications are often found in these venues:

  • American Journal of Transplantation
  • Transplantation
  • Pediatric Transplantation
  • Transplantation Direct
  • Transplant Infectious Disease

The breadth of research demonstrates a consistent focus on transplantation outcomes, immune response mechanisms related to infections including SARS-CoV-2, and clinical studies addressing treatment methods in transplantation and infectious diseases.

Best Publications

  • Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

    Ashley A Vo;Marina Lukovsky;Mieko Toyoda;Jennifer Wang

  • 1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells.

    J M Lemire;J S Adams;R Sakai;S C Jordan

  • Update on the use of immunoglobulin in human disease: A review of evidence

    Elena E. Perez;Jordan S. Orange;Francisco Bonilla;Javier Chinen

  • Evaluation of Intravenous Immunoglobulin as an Agent to Lower Allosensitization and Improve Transplantation in Highly Sensitized Adult Patients with End-Stage Renal Disease: Report of the NIH IG02 Trial

    Stanley C. Jordan;Stanley C. Jordan;Dolly Tyan;Don Stablein;Matthew McIntosh

  • Cell-Free DNA and Active Rejection in Kidney Allografts

    Roy D Bloom;Jonathan S Bromberg;Emilio D Poggio;Suphamai Bunnapradist

  • The impact of donor-specific anti-HLA antibodies on late kidney allograft failure

    Alexandre Loupy;Gary S. Hill;Stanley C. Jordan

  • Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients.

    McDiarmid Sv;Jordan S;Kim Gs;Toyoda M

  • National conference to assess antibody-mediated rejection in solid organ transplantation.

    Steven K. Takemoto;Adriana Zeevi;Sandy Feng;Robert B. Colvin

  • 1,25-Dihydroxyvitamin D3 suppresses human T helper/inducer lymphocyte activity in vitro.

    J. M. Lemire;J. S. Adams;Vali Kermani-Arab;A. C. Bakke

  • IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation.

    Stanley C. Jordan;Tomas Lorant;Jua Choi;Christian Kjellman

  • Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients.

    Jua Choi;Olivier Aubert;Ashley Vo;Alexandre Loupy

  • Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors

    B. J. Orandi;X. Luo;A. B. Massie;J. M. Garonzik-Wang

  • Posttransplant therapy using high-dose human immunoglobulin (intravenous gammaglobulin) to control acute humoral rejection in renal and cardiac allograft recipients and potential mechanism of action

    Stanley C. Jordan;Adrianus W. Quartel;Lawrence S.C. Czer;Dan Admon

  • Th1 and Th2 Cytokine mRNA Profiles in Childhood Nephrotic Syndrome Evidence for Increased IL-13 mRNA Expression in Relapse

    Hui-Kim Yap;Wai Cheung;Belinda Murugasu;Sze-Keen Sim

  • Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.

    Ashley A. Vo;Alice Peng;Mieko Toyoda;Joseph Kahwaji

  • Recommended Treatment for Antibody-mediated Rejection After Kidney Transplantation: The 2019 Expert Consensus From the Transplantion Society Working Group.

    Carrie A. Schinstock;Roslyn B. Mannon;Klemens Budde;Anita S. Chong

  • Intravenous immunoglobulin suppression of HLA alloantibody in highly sensitized transplant candidates and transplantation with a histoincompatible organ.

    Dolly B. Tyan;Victoria A. Li;Lawrence Czer;Alfredo Trento

  • Overexpression of Interleukin-13 Induces Minimal-Change–Like Nephropathy in Rats

    Kin-Wai Lai;Chang-Li Wei;Li-Kiang Tan;Puay-Hoon Tan

  • Intravenous immune globulin treatment inhibits crossmatch positivity and allows for successful transplantation of incompatible organs in living-donor and cadaver recipients.

    S. C. Jordan;A. Vo;S. Bunnapradist;M. Toyoda

  • Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.

    Stanley C. Jordan;Jua Choi;Irene Kim;Gordon Wu

  • Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy

    Asha Moudgil;Cynthia C. Nast;Arvind Bagga;Lin Wei

Frequent Co-Authors

Mieko Toyoda
Mieko Toyoda Cedars-Sinai Medical Center
Mark Haas
Mark Haas Cedars-Sinai Medical Center
Robert A. Montgomery
Robert A. Montgomery New York University
Dorry L. Segev
Dorry L. Segev Johns Hopkins University
Mark D. Stegall
Mark D. Stegall Mayo Clinic
Jon A. Kobashigawa
Jon A. Kobashigawa Cedars-Sinai Medical Center
John P. Roberts
John P. Roberts University of California, San Francisco
Andrea A. Zachary
Andrea A. Zachary Johns Hopkins University School of Medicine
Jonathan S. Bromberg
Jonathan S. Bromberg University of Maryland, Baltimore
Arthur J. Matas
Arthur J. Matas University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, pursuing related healthcare degrees online can open diverse career pathways. Many students who start with a focus on Immunology often consider nursing as a practical application of their knowledge. Programs like online accelerated nursing programs for non nurses offer a fast track for individuals without a nursing background to enter the nursing profession.

If you're seeking less competitive entry points, exploring the easiest accelerated nursing programs can help simplify your transition into nursing, allowing you to build clinical skills alongside your immunology foundation.

For a more technical nursing role, accredited LPN programs easy to get into provide accessible paths to become Licensed Practical Nurses, vital for supporting immunology-related healthcare services.

Furthermore, advancing toward specialized roles, easiest NP programs to get into can guide you to become a Nurse Practitioner, combining clinical expertise with a deeper understanding of immunological health.

Best Scientists Citing Stanley C. Jordan

Trending Scientists

Recently Published Articles